CFM
KLRS

Catalyst Funds Management’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Catalyst Funds Management’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-565
Closed -$10.5K – 1330
2024
Q3 		$10.5K Hold
565
– – ﹤0.01% 1176
2024
Q2 		$9.4K Buy
+565
New +$9.4K ﹤0.01% 941